by nikki mann | Oct 20, 2022 | News
In May 2021, the Milner Institute launched a rapid response data analysis call, led by Dr Rebecca Harris and Dr Namshik Han. The call sought collaborative project proposals from CRUK Cambridge Centre researchers and clinicians with multiomic oncology data sets that...
by nikki mann | Oct 7, 2022 | News
We were delighted to receive an award at the Vice-Chancellor’s Awards for Research, Impact and Engagement last week. Milner Directors Tony Kouzarides and Kathryn Chapman were presented with the runners-up trophy for collaboration at an awards ceremony held at...
by nikki mann | Sep 21, 2022 | News
We are delighted to announce that Alexandra Huener has joined the Milner team as the Head of Entrepreneurship. This exciting new role has been created to lead our expanding initiatives for entrepreneurs here in Cambridge, through the Milner Frame Shift bio-incubator,...
by nikki mann | Sep 5, 2022 | News
The Milner team enjoyed an institute visit with a difference last week, as we welcomed a group of children for Inflammatory Bowel Disease (IBD) Patient Day. The day — organised by Milner collaborator Dr Matthias Zilbauer and the Wellcome MRC Cambridge Stem Cell...
by nikki mann | Aug 3, 2022 | News
Our first ever hybrid Therapeutics Symposium was held at the end of June and we were thrilled to welcome over 350 delegates at West Road Concert Hall, with a further 200+ delegates opting to view the talks via the online symposium platform! A selection of photographs...
by nikki mann | Jul 15, 2022 | News
CardiaTec, a company co-founded by Milner Head of Computational Biology Dr Namshik Han, has secured £1.4 million pre-seed investment to combat cardiovascular diseases using artificial intelligence (AI). CardiaTec is developing a target discovery platform for analysing...